Intussusceptive angiogenesis

From WikiMD's WELLNESSPEDIA

Intussusceptive angiogenesis is a process of blood vessel formation that occurs by splitting of an existing vessel. This process is also known as splitting angiogenesis or non-sprouting angiogenesis. It is one of the two ways in which angiogenesis can occur, the other being sprouting angiogenesis.

Overview[edit]

Intussusceptive angiogenesis is a process that involves the splitting of a pre-existing blood vessel into two new vessels. This process is different from sprouting angiogenesis, which involves the growth of new blood vessels from pre-existing ones. Intussusceptive angiogenesis is a faster process than sprouting angiogenesis and is thought to play a role in the normal growth and development of the vascular system, as well as in the growth of tumors.

Process[edit]

The process of intussusceptive angiogenesis begins with the formation of a transluminal tissue pillar within the lumen of a pre-existing blood vessel. This pillar is formed by the fusion of the opposing endothelial cells lining the vessel. The pillar then expands and splits the vessel into two new vessels. This process is regulated by various growth factors and cytokines, including vascular endothelial growth factor (VEGF) and angiopoietin.

Role in Disease[edit]

Intussusceptive angiogenesis is thought to play a role in the growth of tumors. Tumors require a blood supply to grow, and they can obtain this supply through the process of angiogenesis. Intussusceptive angiogenesis is a faster process than sprouting angiogenesis, making it a potentially important mechanism for tumor growth. In addition, intussusceptive angiogenesis has been implicated in other diseases, such as pulmonary hypertension and retinopathy.

Research[edit]

Research into intussusceptive angiogenesis is ongoing, with the aim of developing new treatments for diseases such as cancer. By understanding the mechanisms of intussusceptive angiogenesis, it may be possible to develop drugs that can inhibit this process and thereby slow the growth of tumors.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.